Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Imprialos

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Circulation|July 13, 2016
Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"Konstantinos Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos
The New England Journal of Medicine|July 14, 2016
Testosterone Treatment in Older MenKonstantinos Stavropoulos, Chrysoula Boutari, Konstantinos Imprialos
Journal of Hypertension|March 30, 2017
Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?Michael Doumas, Konstantinos Stavropoulos, Konstantinos Imprialos
Heart Failure Clinics|September 2, 2019
Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart FailureKonstantinos Imprialos, Konstantinos Stavropoulos, Vasilios Papademetriou
JAMA Internal Medicine|March 9, 2016
Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive FunctionKonstantinos Imprialos, Chrysoula Boutari, Michael Doumas
Current Vascular Pharmacology|December 7, 2017
Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug TreatmentNiki Katsiki, Konstantinos Imprialos, Charalambos Vlachopoulos
Clinical and Molecular Hepatology|May 31, 2019
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular diseaseDimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Exercise, Erectile Dysfunction and Co-Morbidities: "The Good, the Bad and the Ugly"Dimitris Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, et al.
Current Vascular Pharmacology|April 15, 2020
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?Konstantinos Imprialos, Konstantinos Koutsampasopoulos, Athanasios Manolis, et al.
Polish Archives of Internal Medicine|March 1, 2019
Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderlyDimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Circulation|July 13, 2016
Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"Konstantinos Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos
The New England Journal of Medicine|July 14, 2016
Testosterone Treatment in Older MenKonstantinos Stavropoulos, Chrysoula Boutari, Konstantinos Imprialos
Journal of Hypertension|March 30, 2017
Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?Michael Doumas, Konstantinos Stavropoulos, Konstantinos Imprialos
Heart Failure Clinics|September 2, 2019
Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart FailureKonstantinos Imprialos, Konstantinos Stavropoulos, Vasilios Papademetriou
JAMA Internal Medicine|March 9, 2016
Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive FunctionKonstantinos Imprialos, Chrysoula Boutari, Michael Doumas
Current Vascular Pharmacology|December 7, 2017
Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug TreatmentNiki Katsiki, Konstantinos Imprialos, Charalambos Vlachopoulos
Clinical and Molecular Hepatology|May 31, 2019
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular diseaseDimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Exercise, Erectile Dysfunction and Co-Morbidities: "The Good, the Bad and the Ugly"Dimitris Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, et al.
Current Vascular Pharmacology|April 15, 2020
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?Konstantinos Imprialos, Konstantinos Koutsampasopoulos, Athanasios Manolis, et al.
Polish Archives of Internal Medicine|March 1, 2019
Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderlyDimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, et al.
Pageof 6